Results 51 to 60 of about 9,180 (208)
A Benign Cardiac Growth but Not So Indolent
Cardiac lipomatous hypertrophy is a rare benign condition that usually involves the interatrial septum. Due to its benign nature it rarely requires intervention. Its presence outside the interatrial septum is reported infrequently.
Adil S. Wani+3 more
doaj +1 more source
Recurrence of cardiac myxoma. Clinical and morphological aspects
Aim: to conduct a one-center retrospective research of heart myxoma relapses in a large group of patients. Materials and methods. Since 1992 to 2016 115 surgical removal of sporadic cardiac myxoma was performed (44 male, 71 female).Results.
I. M. Iljinsky+3 more
doaj +1 more source
Interatrial septum puncture in an atypical scenario [PDF]
A 57-year-old woman had a patent foramen ovale percutaneous closure with an 18 mm Amplatzer™ device for recurrent ischaemic strokes. Ten years later, balloon cryoablation of pulmonary …
Carmen Exposito+2 more
openaire +3 more sources
Is Transoesophageal Echocardiography Necessary for the Percutaneous Management of Lutembacher Syndrome: A Case Report [PDF]
Lutembacher syndrome is defined as a combination of congenital Atrial Septal Defect (ASD) with an acquired Mitral Stenosis (MS). There are various challenges involved in the percutaneous management of Lutembacher syndrome.
Vamsi Krishna Kamana+4 more
doaj +1 more source
Abstract New data on the equine aortic valve obtained using advanced techniques is especially important given the greater availability of animal models for translational research. Here we characterized the morphological and morphometric aspects of the equine aortic valve from 60 healthy hearts collected at equine abattoirs.
Vitor Pires Pereira+3 more
wiley +1 more source
Lipomatous Hypertrophy of the Interatrial Septum
Lipomatous hypertrophy of the interatrial septum (LHIS) is a rare benign disorder that is characterized by accumulation and deposition of fat in the interatrial septum. Its etiology is still unknown, despite the theories that have been suggested. It usually occurs in older, obese people with a higher incidence in women.
Rachid Boujnah+5 more
openaire +7 more sources
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo+7 more
wiley +1 more source
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz+5 more
wiley +1 more source
Abstract Episodes of worsening heart failure (HF) are a major cause of unplanned hospitalizations. Their onset is usually preceded by an early increase in intracardiac pressures with subsequent worsening of symptoms due to congestion. Implantable devices allowing daily remote pulmonary artery pressure (PAP) monitoring are useful to identify early ...
Antoni Bayes‐Genis+13 more
wiley +1 more source
Arrhythmia‐induced cardiomyopathy (AIC) in left ventricular systolic dysfunction with atrial fibrillation (AF). HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging. Abstract Aims Atrial fibrillation (AF) ablation in heart failure reduces mortality and hospitalizations and ...
Ala Assaf+14 more
wiley +1 more source